Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval

The Lancet Psychiatry ◽

10.1016/s2215-0366(19)30394-3 ◽

2019 ◽

Vol 6 (12) ◽

pp. 977-979 ◽

Author(s):

Erick H Turner

Keyword(s):

Treatment Resistant Depression ◽

Treatment Resistant ◽

Fda Approval ◽

Resistant Depression

Download Full-text

Supplemental Material for Personality and Outcome in Individuals With Treatment-Resistant Depression—Exploring Differential Treatment Effects in the Tavistock Adult Depression Study (TADS)

Journal of Consulting and Clinical Psychology ◽

10.1037/ccp0000391.supp ◽

2019 ◽

Keyword(s):

Treatment Effects ◽

Differential Treatment ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Adult Depression ◽

Resistant Depression

Download Full-text

Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

PsycEXTRA Dataset ◽

10.1037/e651292010-001 ◽

2009 ◽

Author(s):

George I. Papakostas

Keyword(s):

Serotonin Reuptake ◽

Selective Serotonin Reuptake Inhibitors ◽

Serotonin Reuptake Inhibitors ◽

Selective Serotonin ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Resistant Depression

Download Full-text

Treatment resistant depression (TRD): psychopathological profiles and pharmacological outcomes

10.26226/morressier.5785edc9d462b80296c9980d ◽

2016 ◽

Author(s):

Nicolas Nunez

Keyword(s):

Treatment Resistant Depression ◽

Treatment Resistant ◽

Resistant Depression

Download Full-text

Clinical and Neurocognitive Characteristics Associated With Treatment-Resistant Depression

10.26226/morressier.5885d713d462b8028d8910ee ◽

2017 ◽

Author(s):

Gianluca Serafini

Keyword(s):

Treatment Resistant Depression ◽

Treatment Resistant ◽

Resistant Depression

Download Full-text

Intravenous clomipramine for treatment resistant depression

10.26226/morressier.5971be83d462b80290b5308a ◽

2017 ◽

Author(s):

Irene Baldani

Keyword(s):

Treatment Resistant Depression ◽

Treatment Resistant ◽

Resistant Depression

Download Full-text

Safety and efficacy of ketamine infusion in treatment-resistant depression with metabolic syndrome and morbid obesity: a case report

10.26226/morressier.59d4913ad462b8029238a2d8 ◽

2017 ◽

Author(s):

Carolina Nakahira

Keyword(s):

Metabolic Syndrome ◽

Morbid Obesity ◽

Case Report ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Safety And Efficacy ◽

Ketamine Infusion ◽

Resistant Depression

Download Full-text

Neurocognitive Characteristics of Patients With and Without Treatment-resistant Depression

10.26226/morressier.5a7070e3d462b80290b5662e ◽

2018 ◽

Author(s):

Gianluca Serafini

Keyword(s):

Treatment Resistant Depression ◽

Treatment Resistant ◽

Resistant Depression

Download Full-text

History of Ketamine and Itss New Role in Treatment Resistant Depression

10.26226/morressier.5a6ef3efd462b80290b589f1 ◽

2018 ◽

Author(s):

Roohi Abubaker

Keyword(s):

Treatment Resistant Depression ◽

Treatment Resistant ◽

Resistant Depression

Download Full-text

Do cognitive deficits play a role in treatment-resistant depression? Characterizing resistance from cognitive perspective

10.26226/morressier.5b681760b56e9b005965c675 ◽

2018 ◽

Author(s):

Clara Lopez-Sola ◽

Muriel Vicent-Gil ◽

Guillem Navarra Ventura ◽

Diego Jose Palao Vidal

Keyword(s):

Cognitive Deficits ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Cognitive Perspective ◽

Resistant Depression

Download Full-text

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Case Medical Research ◽

10.31525/ct1-nct03887715 ◽

2019 ◽

Author(s):

Keyword(s):

Adjunctive Therapy ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Randomized Controlled ◽

Resistant Depression ◽

Stimulation Control ◽

Download Full-text